Skip to Main Content

2,044

Views

0

CrossRef citations to date

0

Altmetric

Special Report

A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity

Diana I. AlbuCompass Therapeutics Inc, Boston, MA, USACorrespondence[email protected]
View further author information

,

Benjamin J. WolfCompass Therapeutics Inc, Boston, MA, USAView further author information

,

Yan QinCompass Therapeutics Inc, Boston, MA, USAView further author information

,

Xianzhe WangCompass Therapeutics Inc, Boston, MA, USAView further author information

,

Amy Daniel UlumbenCompass Therapeutics Inc, Boston, MA, USAView further author information

,

Mei SuCompass Therapeutics Inc, Boston, MA, USAView further author information

,

Vivian LiCompass Therapeutics Inc, Boston, MA, USAView further author information

,

Eirene DingCompass Therapeutics Inc, Boston, MA, USAView further author information

,

Jose Angel GonzaloCompass Therapeutics Inc, Boston, MA, USAView further author information

,

Jason KongCompass Therapeutics Inc, Boston, MA, USAView further author information

,

Ruturaj JadhavCompass Therapeutics Inc, Boston, MA, USAView further author information

,

Nelly KuklinCompass Therapeutics Inc, Boston, MA, USAView further author information

,

Alberto VisintinCompass Therapeutics Inc, Boston, MA, USAView further author information

,

Bing GongCompass Therapeutics Inc, Boston, MA, USAView further author information

&

Thomas J. SchuetzCompass Therapeutics Inc, Boston, MA, USAView further author information